Edwards Lifesciences Corp【EW】Income statement

Market cap

$49.6B

P/E ratio

	2010/12	2011/12	2012/12	2013/12	2014/12	2015/12	2016/12	2017/12	2018/12	2019/12	2020/12	2021/12	2022/12	2023/12	2024/12
Revenue	1,447	1,679	1,900	2,046	2,323	2,494	2,964	3,435	3,723	4,348	4,386	5,233	5,382	6,005	5,440
Revenue growth (%)	-
Cost of revenue	408	490	495	522	626	617	797	875	939	1,114	1,081	1,249	1,080	1,380	1,118
Gross profit	1,039	1,189	1,405	1,523	1,697	1,877	2,166	2,560	2,783	3,234	3,306	3,984	4,302	4,625	4,322
Gross margin (%)
Research & development	204	246	291	323	347	383	443	553	622	753	761	903	945	1,072	1,053
Selling, general & administrative	550	642	705	746	858	851	905	985	1,089	1,242	1,228	1,494	1,568	1,825	1,789
Operating margin (%)	-	-	-	-	-	-	-	-
Operating income	-	-	-	-	-	-	-	-	748	1,147	898	1,690	1,749	1,534	1,379
Income before tax	268	284	391	515	1,144	622	738	1,035	761	1,167	917	1,702	1,767	1,598	1,548
Pretax margin (%)	18.5	16.9	20.6	25.2	49.2	25	24.9	30.1	20.5	26.8	20.9	32.5	32.8	26.6	28.5
Provision for income taxes	50	47	98	124	333	128	168	451	39	120	93	199	246	199	152
Effective tax rate (%)
Net income	218	-	-	-	-	-	-	-	-	-	-	-	-	1,402	4,175
Net income margin (%)		-	-	-	-	-	-	-	-	-	-	-	-
Earnings per share	1.92	2.07	2.55	3.51	7.62	2.3	2.67	2.77	3.45	5.03	1.32	2.41	2.46	2.31	6.98
Diluted EPS	1.83	1.98	2.48	3.44	7.48	2.25	2.61	2.7	3.38	4.93	1.3	2.38	2.44	2.3	6.97
EBITDA	-	-	-	-	-	-	-	-
EBITDA margin (%)	-	-	-	-	-	-	-	-